USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Shareholders held by USANA Health Sciences Inc. on May 20, 2026. The filing details the outcomes of shareholder votes regarding board elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
A total of 16,468,210 shares (approximately 89% of issued and outstanding shares) were represented at the meeting. The following matters were approved:
- Board of Directors Election: Shareholders elected eight individuals to the Board for the succeeding year. All nominees received significant support, with "For" votes ranging from approximately 13.69 million to 14.13 million shares.
- Auditor Ratification: Shareholders ratified the selection of KPMG LLP as the independent registered public accounting firm for fiscal year 2026. The vote was 16,286,742 shares "For" versus 151,736 "Against".
- Executive Compensation: Shareholders approved, on an advisory basis, the company's executive compensation. The vote was 13,811,489 shares "For" versus 509,777 "Against".
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to reporting the results of the shareholder vote.
Key Facts for Investor Verification
- Verify the official composition of the Board of Directors following the election of the eight new members.
- Confirm the engagement of KPMG LLP for the fiscal year 2026 audit.
- Note the high level of shareholder participation (89%) and the strong approval margins for all three proposals.
- Review the company's subsequent 10-K or 10-Q filings for the financial metrics absent from this 8-K.